STAT - Reporting from the frontiers of health and medicine

Health

Biotech

Health

First Opinion Should ‘broken’ genes be fixed? My daughter changed the way I think about that question
Biotech In a cramped Kendall Square, biotech startups sublet desks and squeeze into shared labs
Biotech Antigen-based metric could better predict which patients benefit from immunotherapy, study says
Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome
First Opinion Human reproductive cloning: The curious incident of the dog in the night-time

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

FDA names genes that may interact with specific drugs, offering clarity to genetic testing industry
Gilead loses another challenge to a pair of U.S. patents for an HIV prevention pill
Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence

In the Lab

Health

Health

Health

Special Report

Health Tech

Health The coronavirus is picking up steam outside China, narrowing chances of eliminating it
Health Once widely criticized, the Wuhan quarantine bought the world time to prepare for Covid-19
Health Experts envision two scenarios if the new coronavirus isn’t contained
Health Tech Aided by machine learning, scientists find a novel antibiotic able to kill superbugs in mice
First Opinion Should ‘broken’ genes be fixed? My daughter changed the way I think about that question